New: NCI-funded clinical trial search
Mednet Logo
CommunityNeurology

How do you treat idiopathic hypersomnia inadequately responding to modafinil?

In light of the recent RCT by Dauvilliers et al., PMID 40359459 published June 2025 in Neurology.
Community PollStarted

Do you use sodium oxybate to treat idiopathic hypersomnia?

123 physicians have voted

Join Mednetto vote and see how they answered.

5 Answers
Mednet MemberInvited Expert
Neurology · UNC Health
Answered on · Updated on

I agree with @Dr. First Last. I usually start my patients on modafinil or armodafinil. If those do not work, I will try solriamfetol. I will supplement with as needed amphetamines as well. I do not often go straight to sodium oxybate/low-sodium oxybate, as you need the right patient for this medication. They have to be in a safe living situation and have no need to wake in the middle of the night. This leaves out college students living in dorms. This also leaves out parents with young children ...

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Neurology · Northwestern University
Answered on

I would try a traditional stimulant first, and if they have side effects, then switch to low-sodium oxybate.

Join for free or sign in to see the full answer

Mednet Member
Pulmonology · Sanford Health
Answered on

Although I agree with modafinil or armodafinil as a first-line, amphetamines are problematic both in the mood disorders associated with idiopathic hypersomnolence and in college students. Solriamfetol is intriguing, but since IH is an off-label indication, insurers routinely deny it. Overall, sodium oxybate has had a rather excellent side effect profile when it is carefully monitored. Sodium oxybate appears to be a game changer for the ten patients taking it under my care.

Join for free or sign in to see the full answer

Mednet Member
Psychiatry · Jennifer Neuwalder, MD
Answered on

The one patient I work with who has idiopathic hypersomnia also has other dysautonomias, so I referred out to a sleep specialist. It took over two years for them to get approved for Xywav because their sleep study was slightly off, and not many physicians prescribed GHB. My patient experienced a brief psychotic episode when the titration was too rapid. The titration was resumed at a slower pace and was well tolerated. They continue to take modafinil, with partial efficacy, but Xywav has signific...

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Neurology · Brown University
Answered on

In reviewing the AASM practice guidelines 2021 (1), clarithromycin also has RCT evidence to support it, but must be used cautiously in those with comorbid heart disease, and being wary of the development of antibiotic resistance. Flumazenil also has interesting retrospective data to support it (2) [I am biased as I am grateful to have had a small part in this paper], but was ultimately deemed insufficient/inconclusive for the AASM guideline (1, 3).

That said, I have not tried sodium-oxybate yet, ...

Join for free or sign in to see the full answer